SCHEMBL30879077

SCHEMBL30879077

CSc1ncc2c(O)cc(=O)n(C(C)C)c2n1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.39
TTK P33981 2/20 0.39
PIM2 Q9P1W9 2/20 0.39
PIK3CA P42336 5/20 0.35
MTOR P42345 3/20 0.35
CDK4 P11802 2/20 0.35
CCND1 P24385 2/20 0.35
CCND2 P30279 2/20 0.35
CCND3 P30281 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPK8 P45983 3/20 0.31
MAPK10 P53779 2/20 0.31
MAPK9 P45984 1/20 0.31
NTRK1 P04629 1/20 0.31
CASR P41180 1/20 0.30
USP19 O94966 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1318966 0.85 CDK4 (0.47) PIM1TTKPIM2PIK3CAMTOR
SCHEMBL30878721 0.77 PIM1 (0.35) PIM1TTKPIM2PIK3CACDK4
SCHEMBL1226673 0.76 CYP1A2 (0.37) PIM1TTKPIM2CDK4CCND1
SCHEMBL30879185 0.75 APLNR (0.41) CDK4CCND1CCND2CCND3MEN1
SCHEMBL1226190 0.75 APLNR (0.41) CDK4CCND1CCND2CCND3MEN1
SCHEMBL1226546 0.74 CDK4 (0.41) CDK4CCND1CCND2CCND3MEN1
SCHEMBL30878784 0.74 CDK4 (0.41) CDK4CCND1CCND2CCND3MEN1
SCHEMBL22190643 0.74 KDM4E (0.38) PIM1TTKPIM2CDK4CCND1
SCHEMBL30278828 0.74 KDM4E (0.38) PIM1TTKPIM2CDK4CCND1
SCHEMBL29991137 0.74 CDK4 (0.54) PIM1TTKPIM2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed